PIII P3 Health Partners Inc.
Services-Health Services · Nasdaq · SEC CIK 1832511 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY7.5%
TTM net income YoY60.9%
TTM EPS YoY47.3%
Revenue 3-yr CAGR9.7%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-5.2%
Net margin-3.3%
FCF margin—
EBITDA margin0.2%
Returns
ROE-115.7%
ROA-7.6%
ROIC (approx.)-33.7%
Asset turnover2.30x
Leverage & solvency
Liabilities / assets70.0%
Debt / equity1.14x
Current ratio0.53x
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.26x
Accruals ratio9.5%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2024Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $396.34M | $386.38M | $386.39M | $384.81M | $345.25M | $355.79M | $373.23M | $370.69M |
| SG&A expense | $34.27M | $32.39M | $25.54M | $35.88M | $22.39M | $23.45M | $25.00M | $31.37M |
| Operating income | $22.98M | $41.23M | $8.24M | -$153.87M | -$44.22M | -$34.12M | -$38.09M | -$138.50M |
| Pretax income | $30.80M | $16.92M | -$7.96M | -$166.75M | -$69.45M | -$41.68M | -$43.17M | -$124.20M |
| Income tax | $23,000 | $1.26M | -$11.00M | -$1.04M | $11,000 | $1.98M | $1.07M | $4.95M |
| Net income | $15.62M | $7.44M | $1.22M | -$75.52M | -$31.59M | -$20.36M | -$20.48M | -$58.62M |
| EBITDA | $44.02M | $62.27M | $29.31M | -$132.87M | -$23.19M | -$13.04M | -$17.04M | -$117.35M |
| EPS (basic) | 0.13 | -0.63 | 0.37 | — | -9.67 | -6.23 | -6.28 | — |
| EPS (diluted) | 0.07 | -0.63 | 0.32 | — | -9.67 | -6.23 | -6.28 | — |
| Weighted avg. shares (diluted) | 6.63M | 3.36M | 8.42M | — | 3.27M | 3.27M | 3.26M | — |
| Banking | ||||||||
| Net interest income | -$5.04M | -$7.86M | -$16.77M | -$15.64M | -$20.53M | -$10.14M | -$8.72M | -$6.83M |
| Balance sheet | ||||||||
| Cash & equivalents | $43.90M | $21.27M | $25.50M | $25.01M | $37.71M | $38.58M | $40.08M | $44.10M |
| Current assets | $216.03M | $179.34M | $172.21M | $133.08M | $135.63M | $156.53M | $191.44M | $184.14M |
| PP&E, net | $2.15M | $2.53M | $2.96M | $3.37M | $3.90M | $4.69M | $5.31M | $5.73M |
| Intangibles | $431.82M | $452.40M | $472.99M | $492.42M | $512.91M | $533.40M | $553.89M | $574.35M |
| Total assets | $669.72M | $654.39M | $674.16M | $656.64M | $683.56M | $731.59M | $783.87M | $783.42M |
| Current liabilities | $406.65M | $388.58M | $525.49M | $545.26M | $423.95M | $505.00M | $507.03M | $496.42M |
| Short-term debt | $84.43M | $21.80M | $51.44M | $45.04M | $38.61M | $80.00M | $65.00M | $75.16M |
| Long-term debt | $37.33M | $98.05M | $259.57M | $228.37M | $214.18M | $101.96M | $106.12M | $108.91M |
| Total debt | $121.76M | $119.85M | $311.00M | $273.41M | $252.79M | $181.96M | $171.12M | $184.06M |
| Total liabilities | $469.00M | $516.75M | $807.32M | $796.88M | $664.64M | $644.41M | $662.79M | $633.89M |
| Shareholders' equity | $107.27M | $72.19M | -$144.91M | -$155.23M | -$18.69M | $44.46M | $63.25M | $75.94M |
| Net debt | $77.86M | $98.58M | $285.51M | $248.40M | $215.08M | $143.38M | $131.04M | $139.96M |
| Cash flow statement | ||||||||
| Operating cash flow | -$685,000 | -$61.91M | -$27.47M | -$25.73M | -$15.41M | -$16.63M | -$33.47M | -$57.24M |
| Capital expenditure | — | — | — | — | — | — | — | $0 |
| Free cash flow | — | — | — | — | — | — | — | -$57.24M |
| Investing cash flow | $0 | -$208,000 | -$43,000 | $198,000 | -$119,000 | $50,000 | $0 | -$475,000 |
| Financing cash flow | $24.29M | $58.21M | $27.80M | $12.87M | $14.67M | $14.62M | $30.66M | $33.72M |
| Depreciation & amortization | $21.04M | $21.04M | $21.07M | $21.00M | $21.03M | $21.08M | $21.05M | $21.15M |
| Stock-based compensation | -$421,000 | $866,000 | $1.05M | $1.10M | $1.21M | $1.46M | $1.81M | $721,000 |
Free plan shows the latest 8 periods; Pro shows all 22 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.